significantly after tumor resection, and patients with persistently high CTC load 1 showed a propensity of tumor recurrence after surgery. Patients treated with resectable operation were followed up every 2 months qRT-PCR test platform was utilized, with negative enrichment to optimize CTC 21 detection. 15 In brief, samples first were negatively enriched, using RosetteSep qRT-PCR in an independent and divided screening group of 100 subjects were <0.05 by logistic regression (Table S2) . 21 Consequently, a backward logistic regression model was applied to estimate In accordance with our logistic regression equation, a predicted probability was 8 registered for each member of the training set. These values were significantly 9 higher in patients with HCC (n=200) versus CHB/LC (n=101) or HD groups 10 (n=100) (both P<0.001, Figure 2A ). Further ROC analysis in patients with
11
HCC versus CHB/LC and HD showed optimal diagnostic cutoff value of 0.57
12
(criteria for optimal sensitivity plus specificity, optimal Youden index) for CTC 71.1%, Figure 2B ). Figure 2C ). 1 The CTC panel outperformed AFP as a biomarker in terms of differential 2 diagnostic capability, yielding higher AUC, sensitivity, and specificity in HCC 3 (n=200) and CHB/LC group (n=101) comparisons ( Figure 3C, Table 2 ). In the 
CCR-17-1753
The potential utility of the CTC panel in therapeutic response evaluation was 1 further investigated in 60 resectable HCC patients. We found that the CTC Figure 4C and Table S5 ). Furthermore, in 
and Table 2 ). Furthermore, the excellent diagnostic performances of our panel 1 were sustained in AFP-negative subsets of HCC (Table S4) Indeed, small-sized lesions of HCC could be detected in subjects at risk, 
persistently high CTC load postoperatively showed a propensity of increased 1 tumor recurrence, and this suggested that our CTC panel might be a surrogate 2 indicator for surveillance of the treatment response during HCC management.
3
In addition, further study focus on these CTC subpopulations (such as 4 EpCAM + , CD90 + , CD133 + , and CK19 + ) will be present more information for 5 metastatic mechanism as well as related therapeutic targets. Epithelial-mesenchymal transition (EMT) is essential for circulatory invasion by 7 tumor cells, which become CTCs, and EMT markers are also candidate 8 indices of CTCs. 36 We evaluated expression patterns of two major EMT 9 markers (E-cadherin and Vimentin) in 89 patients with HCC patients and in 70 10 HD subjects, and there had no significant difference in two groups ( Figure S8 ).
11
To our knowledge, this is the first large-scale, multicenter study to report the 12 utility of CTCs detection in HCC diagnosis, prognosis as well as therapeutic Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: 
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